Biomedical subjects

M B Shcherbinina

Publications and source records attributed to M B Shcherbinina.

3 recordsLinked to original sources

PubMed2005

[Continuum of Helicobacter pylori infection as the scientific substantiation for taking clinical decisions].

The article describes diseases of the gastroduodenal zone in the continuum of Helicobacter pylori infection. It discloses factors of risk and state of human health that increase the chance of the development of this or that disease and have an effect on its development and its complications that may lead to death. The article also disclosed a possibility of arresting the man's movement along the way of this continuum.

Gastrointestinal Diseases↗

PubMed1992

[Segmental reflexes after sciatic nerve damage in rats given thyroxine].

Amplitude of the L5 segmental reflex responses 20 min. before and after intraperitoneal introduction of obsidan, clopheline and finoptine was recorded in experiments on spinalized and thyroxinized rats which 3 weeks before have endured transection of the sciatic nerve. It is demonstrated that obsidan does not change the amplitude of the monosynaptic reflex responses of the ventral root restored under the effect of thyroxine at the operated side, while clopheline and finoptine mainly reduce it.

Animals↗

PubMedDate not supplied

[Effect of preceding acid-reducing therapy on the Helicobacter pylori eradication rate in patients with ulcerous disease].

32 patients having for the last one or two years an episode of exacerbation of stomach ulcer disease associated with Helicobacter pylory had received 7 days Helicobacter eradicative therapy of the first line according to Maastricht consensus-2, 2002 year. All the patients were divided into 2 groups. 15 persons of the first group have received just after establishing diagnosis antihelicobacter therapy, other 17 patients of the second group preliminarily over the period of 2-3 weeks had been treated with proton pomp's inhibitor. Helicobacter pylori eradication rate in the first and second group was 93,3% and 52,9% respectively. The obtained results enable us to discuss the regimen of rational medical therapy of patients with Helicobacter pylori associated diseases.

Adult↗